371
Views
1
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

A retrospective study of tunnelled haemodialysis central line-associated bloodstream infections

, , & ORCID Icon
Pages 132-136 | Received 24 Jan 2019, Accepted 11 Mar 2019, Published online: 01 Apr 2019

References

  • ANZDATA. The 39th annual ANZDATA report. Australia and New Zealand Transplant Registry, South Australia, Adelaide; 2016. Available from: www.anzdata.org.au/v1/report_2016.html.
  • Excerpts from the USRDS. 1997. Annual Report. IV. USRDS dialysis morbidity and mortality study. Wave 2. Am J Kidney Dis. 1997;30(Suppl 1):S67–S85.
  • Vanholder R, Canaud B, Fluck R, Jadoul M, Laura L, Monros A, et al. Diagnosis, prevention and treatment of haemodialysis catheter—related blood stream infections (CRBSI): a position statement of European Renal Best Practice. Nephrol Dial Transplant. 2010;3(3):234–6.
  • Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997;127:275–80.
  • Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis. 1999;34:1114–24.
  • Allon M. Dialysis catheter related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44:779–91.
  • Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systemic review. J Am Soc Nephrol. 2013;24:465–73.
  • Rabindrath KS, Bansal T, Adams J, Das R, Shail R, MacLeod AM, et al. Systemic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2009;24(12):3763.
  • Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, et al. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Clin J Am Soc Nephrol. 2014;9(7):1232–39.
  • Zhang J, Wang B, Li R, Ge L, Chen KH, Tian J. Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis. Int Urol Nephrol. 2017;49:701–16.
  • Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010;5(10):1799.
  • Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol. 2002;13(8):2133.
  • Corbett R, Ashby D, Edwards C, Prout V, Singh S, Bedi R, et al. A randomised control trial of taurolidine-heparin-citrate line locks in prevention of recurrence of catheter related bacteraemia in haemodialysis patients. Nephrol Dial Transplant. 2013;28(Suppl 1):i19–i21, SO063.
  • Solomon L, Cheesborough J, Ebah L, Heap M, Millband N, Waterhouse D, et al. A randomised, double blind, controlled trial of taurolidine-citrate catheter locks for the preventions of bacteraemia in patients treated with haemodialysis. Am J Kidney Dis. 2010;55(6):1060–8.
  • Zwiech R, Adelt M, Chrul S. A taurolidine-citrate-heparin lock solution effectively eradicates pathogens from the catheter biofilm in hemodialysis patients. Am J Ther 2016;23(2):e363–368.
  • Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant. 2004;19:1546–51.
  • Arechabala MC, Catoni MI, Claro JC, Rojas NP, Rubio ME, Calvo MA, et al. Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis. Cochrane Database Syst Rev 2018;4:CD010597.
  • Health Infection Surveillance WA. HISWA Surveillance Manual 2014. Accessed November 2017. Available from: http://ww2.health.wa.gov.au/∼/media/Files/Corporate/general%20documents/Infectious%20diseases/PDF/HISWA/surveillance-manual-version-6-oct-2014.pdf.
  • Horan TC, Andrus M, Dudeck MPH. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infection in the acute care setting. Am J Infect Control. 2008;36:309–32.
  • Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96(3):200.
  • Kairaitis LK, Gottlieb T. Outcome and complications of temporary haemodialysis cathethers. Nephrol Dialysis Transplant. 1999;14:1710–14.
  • Marley J, Dent H, Wearne M, Fitzclarence C, Nelson C, Siu K, et al. Haemodialysis outcomes of Aboriginal and Torres Strait Islander patients of remote Kimberley region origin. Med J Aust. 2010;193(9):516–20.
  • Boan P, Tan HL, Pearson J, Coombs G, Heath CH, Robinson JO. Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: a case control study. BMC Infect Dis. 2015;15:10.
  • Boan P, Swaminathan R, Irish A. Infectious complications in indigenous renal transplant recipients in Western Australia. Intern Med J. 2017;47(6):648–55.
  • Beathard, GA. Management of bacteremia associated with tunnelled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999;10:1045–9.
  • Mermel LA., Allon M., Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter related infection: 2009 update by the Infectious Disease Society of America. Clin Infect Dis. 2009;49(1):1–45.
  • Allon, M. Treatment guidelines for dialysis catheter-related bacteremia: an update. Am J Kidney Dis. 2009;54(1):13–7.
  • Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002;34(12):1653–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.